HBK Investments’s Immunomedics Inc IMMU Stock Holding History

HBK Investments’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,500,000	Closed	-$553M	–	835
2020 Q3	$553M	Buy	+6,500,000	New	+$329M	4.13%	3
2019 Q1	–	Sell	-51,275	Closed	-$732K	–	1468
2018 Q4	$732K	Sell	51,275 -273,045	-84%	-$5.42M	0.01%	780
2018 Q3	$6.76M	Buy	+324,320	New	+$7.68M	0.05%	226

HBK Investments's IMMU Position: Q4 2020 in Review

HBK Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 6,500,000 shares — an estimated $553M sold.

HBK Investments first reported a position in IMMU in Q3 2018 and held it in 3 quarters. The position peaked at $553M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

HBK Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
HBK Investments sold 6,500,000 Immunomedics Inc shares in Q4 2020, an estimated $553M.
HBK Investments first reported a position in Immunomedics Inc in Q3 2018 and held it in 3 quarters.
HBK Investments's Immunomedics Inc position peaked at $553M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.